Top Markets
Coin of the day
Hubei Biocause Heilen Pharmaceutical Co., Ltd. Hubei Biocause Heilen Pharmaceutical Co., Ltd.

Hubei Biocause Heilen Pharmaceutical Co., Ltd.

301211
Rank in Stocks #10977
Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese enterprise with... Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese enterprise with diverse operations spanning the pharmaceutical, chemical, and new energy fuel sectors. Within its pharmaceutical segment, the company manufactures active pharmaceutical ingredients (APIs), various intermediates, and finished drug formulations. Furthermore, its chemical offerings include industrial products such as dimethyl ether gas and chloropropionyl chloride. The firm is headquartered in Jingmen, China.
Share Price
$1.82
Last synced: 2026-08-28
Market Cap
$760.08M
Change (1 day)
-3.16%
Change (1 year)
3.42%
Country
CN
Trade Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211)

Category

Operating Margin for Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211)
Operating Margin as of 2026 TTM: 0.00%
According to Hubei Biocause Heilen Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Hubei Biocause Heilen Pharmaceutical Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
25.56% -
JP
6.22% -
TW
0.00% -
DE
5.98% -
SA
-0.42% -
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.